DDR, DNA damage response; EGFR, epidermal growth factor receptor; ER, estrogen receptor; HER2, human epidermal growth factor receptor 2; NSCLC, non-small-cell lung cancer; PARP, poly (ADP-ribose) polymerase; PR, progesterone receptor. This evidence concerns the gene ERBB2 and non-small cell lung carcinoma.